Nine Chapters Capital Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q3
Sell
-28,300
Closed -$211K 1261
2015
Q2
$211K Sell
28,300
-17,200
-38% -$128K 0.02% 803
2015
Q1
$272K Sell
45,500
-9,800
-18% -$58.6K 0.02% 744
2014
Q4
$418K Buy
+55,300
New +$418K 0.04% 588
2014
Q2
Sell
-44,100
Closed -$180K 1192
2014
Q1
$180K Buy
+44,100
New +$180K 0.02% 730
2013
Q4
Sell
-12,200
Closed -$61K 992
2013
Q3
$61K Sell
12,200
-4,500
-27% -$22.5K 0.01% 709
2013
Q2
$74K Buy
+16,700
New +$74K 0.01% 601